Liver Cancer Survival Rates

Liver cancer survival rates. There is a steady increase in the number of people suffering from the chronic liver disease in recent decades. This is a major cause of concern around the world. Liver cancer when it is in the liver itself becomes primary liver cancer. When cancer expands to the liver from other parts of the body, it is called seared liver cancer. In the United States, primary liver cancer is rarely found. Only 2% of all malignancies in the United States is the primary liver cancer, while in Africa and Asia, approximately 10% and 50% of the cancers are primary liver cancer. Hepatocellular carcinoma (HCC) is one of the ten most common cancers in the world. It is more common in men than in women. About 75% of primary liver cancer cases are considered to be HCC cases.

The incidence of seared liver cancer in the US is approximately 20 times that of primary liver cancer. When the blood through the liver through filtration, the rest of the cancer cells in the liver and transformed into secondary tumors. Therefore, the primary tumor is present in other organs (metastasis). This type of liver cancer is called liver metastasis.




The risk factors for liver cancer
The precarious causes of liver cancer are not yet known. However, there are some items that some people are at greater risk of developing liver cancer. Age, genetics (family history of liver cancer), gender, the presence of carcinogens in the environment, the use of some oral contraceptives, cirrhosis, alcohol abuse, hepatitis and hemochromatosis exposure (too much iron in the liver) are some of the factors that increase the risk of liver cancer.

Factors that affect survival opportunities
Liver cancer survival rates, the percentage of people who survive after the diagnosis of liver cancer over a certain period of time. In general, this period is five years. The people who are living five years after the diagnosis of liver cancer are usually taken into account for the calculation of cancer survival. Different factors influence the chance of survival. Therefore, you can not predict "Liver life expectancy of a patient with cancer, with the help of survival chances or other statistics. The treatment and response of the patient to treatment vary greatly from patient to patient. The stage at diagnosis (if the tumor is restricted to the origin or has penetrated other parts), liver function status, general health of the patient and whether he is following a "healthy lifestyle". The prognosis of liver cancer and influence in its once, the chance of survival as well. The alpha-fetoprotein (AFP) also determines the survival rate of liver cancer. If cancer is discovered at an earlier stage, the chance of survival is obviously high. Periodic evaluation and consultation with a doctor, assist in early detection of cancer.

Survival rates
The researchers' statistics are based on the data of a large number of patients. The purpose for which these rates are calculated, and how, while calculating these rates may be different in different places. According to available statistics, a few years ago, the overall survival rate of liver cancer over five years after diagnosis was about 9%. When comparing data, the survival figures are taken into account for five years.

• Age: According to the American Cancer Society, the average age of people when they are liver cancer is 66. The maximum number (about 27%) of the liver cancer population belonged to the age group 65-74. About 21% of people belonged to the age groups 55-64 and 75-84.
• Gender and race: A few years ago, the survival rate for cancer occurs in the liver about 10.5% of white women, while it was about 7.5% for white men. For men blacks were about 5.5% while women in color, which was about 4.5%.
• Stages of liver cancer: The data can still be subdivided into the following headings:

1. Localized Stage: If it detects early cancer, approximately 19% of patients are able to survive for five years or more. The percentage of patients with a diagnosis of the first stage approximately 30%.
2. Beyond the primary site: About 6.5% of patients are able to survive for five years, as doctors believe that cancer has spread beyond the original site, but only around the regional lymph nodes. About 26% of the cases diagnosed when cancer in the second stage.
3. Disease in cancer: The survival rate of five years liver cancer is approximately 3.5% when the cancer has begun to enter orbital bodies (when it is at a distance or when the cancer is already sown). Nearly 22% of liver cancer cases have been diagnosed after cancer reaches the distance stage.
4. No Information Phase: During data collection, approximately 22% of cases were diagnosed with liver cancer, information on the stage of diagnosis is not available. The five-year survival rate for these cases was estimated to be about 3.4%.

• Liver transplant: Survival rates are higher than 75%, after liver transplantation. But in developing countries, more than 70% of the cases an operation cannot be considered as a possible option liver cancer often diagnosed in the final stage or removed. For liver saturated liver, the survival rate is almost zero because cancer is present in different organs and is likely to spread to the new liver after surgery of liver transplant, sooner or later. If the disease is detected at an early stage, the survival rate after liver transplantation, or after removal of the liver cancer, can reach up to 80%.
• Metastatic liver: Age, general health, mental health, availability of advanced treatments, etc., to determine sown liver cancer survival rate. In fact, this type of survival is very rare. Yet, with advanced treatments like chemoembolization and hepatectomy, about 55% of patients can survive for five years.

Every case of cancer is unique. Statistics should not be used to guess what will happen to a person who is struggling with cancer. The rate of growth of cancer can vary from person to person. Patients can choose different types of treatments. It should be noted that statistics are useful scientists and medical researchers. Not to be used to predict a patient's life expectancy.

*Image source : USC Department of Surgery

References :

1. National Cancer Institute
2. sulla-salute.com
3. American Cancer Society